Convergence Pharmaceuticals' Death

Convergence Pharmaceuticals raised a round of funding on May 12, 2017. Investors include Dead.

Convergence Pharmaceuticals is an independent biotechnology company focused on the development of novel analgesics with potentially commercially attractive efficacy, responder-rate and side effect pro…

Articles about Convergence Pharmaceuticals' Death: